BIRB 796 has Distinctive Anti-inflammatory Effects on Different Cell Types |
Ryoo, Soyoon
(Laboratory of Cytokine Immunology, Department of Biomedical Sciences and Technology, Konkuk University)
Choi, Jida (Laboratory of Cytokine Immunology, Department of Biomedical Sciences and Technology, Konkuk University) Kim, Jaemyung (Division of Veterinary Bacterial Disease Division, Animal and Plant Quarantine Agency) Bae, Suyoung (Laboratory of Cytokine Immunology, Department of Biomedical Sciences and Technology, Konkuk University) Hong, Jaewoo (Laboratory of Cytokine Immunology, Department of Biomedical Sciences and Technology, Konkuk University) Jo, Seunghyun (Laboratory of Cytokine Immunology, Department of Biomedical Sciences and Technology, Konkuk University) Kim, Soohyun (Laboratory of Cytokine Immunology, Department of Biomedical Sciences and Technology, Konkuk University) Lee, Youngmin (Department of Medicine, Pusan Paik Hospital, Collage of Medicine, Inje University) |
1 | Lee, J. C., J. T. Laydon, P. C. McDonnell, T. F. Gallagher, S. Kumar, D. Green, D. McNulty, M. J. Blumenthal, J. R. Heys, S. W. Landvatter, J. E. Strickler, M. M. McLaughlin, I. R. Siemens, S. M. Fisher, G. P. Livi, J. R. White, J. L. Adams, and P. R. Young. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372: 739-746. DOI ScienceOn |
2 | Hanks, S. K., A. M. Quinn, and T. Hunter. 1988. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241: 42-52. DOI |
3 | Hale, K. K., D. Trollinger, M. Rihanek, and C. L. Manthey. 1999. Differential expression and activation of p38 mitogen- activated protein kinase alpha, beta, gamma, and delta in inflammatory cell lineages. J. Immunol. 162: 4246-4252. |
4 | van den Blink, B., J. Branger, S. Weijer, A. Gupta, S. J. van Deventer, M. P. Peppelenbosch, and T. van der Poll. 2004. P38 mitogen activated protein kinase is involved in the downregulation of granulocyte CXC chemokine receptors 1 and 2 during human endotoxemia. J. Clin. Immunol. 24: 37-41. DOI ScienceOn |
5 | Ono, K. and J. Han. 2000. The p38 signal transduction pathway: activation and function. Cell. Signal. 12: 1-13. DOI ScienceOn |
6 | Kumar, S., J. Boehm, and J. C. Lee. 2003. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat. Rev. Drug Discov. 2: 717-726. DOI ScienceOn |
7 | Sundell, C. L., P. K. Somers, C. Q. Meng, L. K. Hoong, K. L. Suen, R. R. Hill, L. K. Landers, A. Chapman, D. Butteiger, M. Jones, D. Edwards, A. Daugherty, M. A. Wasserman, R. W. Alexander, R. M. Medford, and U. Saxena. 2003. AGI-1067: a multifunctional phenolic antioxidant, lipid modulator, anti-inflammatory and antiatherosclerotic agent. J. Pharmacol. Exp. Ther. 305: 1116-1123. DOI ScienceOn |
8 | Kuma, Y., G. Sabio, J. Bain, N. Shpiro, R. Marquez, and A. Cuenda. 2005. BIRB796 inhibits all p38MAPK isoforms in vitro and in vivo. J. Biol. Chem. 280: 19472-19479. DOI ScienceOn |
9 | Luyendyk, J. P., J. D. Piper, M. Tencati, K. V. Reddy, T. Holscher, R. Zhang, J. Luchoomun, X. Chen, W. Min, C. Kunsch, and N. Mackman. 2007. A novel class of antioxidants inhibit LPS induction of tissue factor by selective inhibition of the activation of ASK1 and MAP kinases. Arterioscler. Thromb. Vasc. Biol. 27: 1857-1863. DOI ScienceOn |
10 | Choy, E. H. and G. S. Panayi. 2001. Cytokine pathways and joint inflammation in rheumatoid arthritis. N. Engl. J. Med. 344: 907-916. DOI ScienceOn |
11 | Branger, J., B. van den Blink, S. Weijer, A. Gupta, S. J. van Deventer, C. E. Hack, M. P. Peppelenbosch, and T. van der Poll. 2003. Inhibition of coagulation, fibrinolysis, and endothelial cell activation by a p38 mitogen-activated protein kinase inhibitor during human endotoxemia. Blood 101: 4446-4448. DOI ScienceOn |
12 | Uddin, S., J. Ah-Kang, J. Ulaszek, D. Mahmud, and A. Wickrema. 2004. Differentiation stage-specific activation of p38 mitogen-activated protein kinase isoforms in primary human erythroid cells. Proc. Natl. Acad. Sci. U. S. A. 101: 147-152. DOI ScienceOn |
13 | Hsu, H. Y. and M. H. Wen. 2002. Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. J. Biol. Chem. 277: 22131-22139. DOI ScienceOn |
14 | Branger, J., B. van den Blink, S. Weijer, J. Madwed, C. L. Bos, A. Gupta, C. L. Yong, S. H. Polmar, D. P. Olszyna, C. E. Hack, S. J. van Deventer, M. P. Peppelenbosch, and T. van der Poll. 2002. Anti-inflammatory effects of a p38 mitogen- activated protein kinase inhibitor during human endotoxemia. J. Immunol. 168: 4070-4077. DOI |
15 | Dinarello, C. A. 2004. Interleukin-18 and the treatment of rheumatoid arthritis. Rheum. Dis. Clin. North. Am. 30: 417-434, ix. DOI |
16 | Feldmann, M., F. M. Brennan, and R. N. Maini. 1996. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14: 397-440. DOI ScienceOn |
17 | Jarvis, B. and D. Faulds. 1999. Etanercept: a review of its use in rheumatoid arthritis. Drugs 57: 945-966. DOI |
18 | Weinblatt, M. E., J. M. Kremer, A. D. Bankhurst, K. J. Bulpitt, R. M. Fleischmann, R. I. Fox, C. G. Jackson, M. Lange, and D. J. Burge. 1999. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N. Engl. J. Med. 340: 253-259. DOI ScienceOn |
19 | Schafer, P. H., L. Wang, S. A. Wadsworth, J. E. Davis, and J. J. Siekierka. 1999. T cell activation signals up-regulate p38 mitogen-activated protein kinase activity and induce TNF-alpha production in a manner distinct from LPS activation of monocytes. J. Immunol. 162: 659-668. |
20 | Debnath, J., M. Chamorro, M. J. Czar, E. M. Schaeffer, M. J. Lenardo, H. E. Varmus, and P. L. Schwartzberg. 1999. rlk/TXK encodes two forms of a novel cysteine string tyrosine kinase activated by Src family kinases. Mol. Cell. Biol. 19: 1498-1507. DOI |
21 | Mendelson, K. G., L. R. Contois, S. G. Tevosian, R. J. Davis, and K. E. Paulson. 1996. Independent regulation of JNK/p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver. Proc. Natl. Acad. Sci. U. S. A. 93: 12908-12913. DOI ScienceOn |
22 | Lee, J. C., D. E. Griswold, B. Votta, and N. Hanna. 1988. Inhibition of monocyte IL-1 production by the anti-inflammatory compound, SK&F 86002. Int. J. Immunopharmacol. 10: 835-843. DOI ScienceOn |
23 | Pargellis, C., L. Tong, L. Churchill, P. F. Cirillo, T. Gilmore, A. G. Graham, P. M. Grob, E. R. Hickey, N. Moss, S. Pav, and J. Regan. 2002. Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site. Nat. Struct. Biol. 9: 268-272. DOI ScienceOn |